|
|
Previous Article | Table of Contents | Next Article 
Measurement of basal levels of factor VIIa in hemophilia A and B patients
[see comments]
P Wildgoose, Y Nemerson, LL Hansen, FE Nielsen, S Glazer and U Hedner
Novo Nordisk A/S, Biopharmaceuticals Division, Gentofte, Denmark.
Previous results, presented in abstract form, indicate that replacement of
thromboplastin with a mixture of phospholipid and truncated soluble tissue
factor apoprotein results in a coagulation assay that can directly measure
plasma factor VIIa levels without interference from zymogen factor VII
(Atherosclerosis Thromb 11:1544a, 1991 [abstr]). We have exploited the
specificity and sensitivity of such a factor VIIa specific coagulation
assay to directly assess the in vivo relationship of factor VIII and factor
IX on the production of factor VIIa levels under nonthrombotic and
nonstimulatory conditions. Normal individuals (n = 20) were found to
possess an average circulating factor VIIa level corresponding to 4.34 +/-
1.57 ng/mL, or approximately 1% of their total factor VII antigen. Severe
factor VIII deficient patients (n = 13) possessed a slightly lower but
statistically significant (P less than .01) decrease in their basal factor
VIIa levels (2.69 +/- 1.52 ng/mL), corresponding to approximately 60% of
that observed in normal individuals. On the other hand, severe factor IX
deficient patients (n = 7) were found to possess even lower levels of
factor VIIa corresponding to 0.33 +/- 0.15 ng/mL, or less than 10% of that
observed in normal individuals. Measurement of total factor VII antigen
levels shows that the variation in basal factor VIIa levels stems from
differences in the degree of factor VII activation as opposed to
differences in factor VII antigen levels. Our present data are consistent
with the hypothesis that factor IXa is the principal in vivo activator of
factor VII under basal conditions.
Volume 80,
Issue 1,
pp. 25-28,
07/01/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Hedner and M. Ezban
Recent advances in clot biology and assessment of clotting
Trauma,
October 1, 2008;
10(4):
261 - 270.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2005;
25(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tranholm, K. Kristensen, A. T. Kristensen, C. Pyke, R. Rojkjaer, and E. Persson
Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A
Blood,
November 15, 2003;
102(10):
3615 - 3620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. van 't Veer, N. J. Golden, and K. G. Mann
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa
Blood,
February 15, 2000;
95(4):
1330 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. van 't Hooft, A. Silveira, P. Tornvall, A. Iliadou, E. Ehrenborg, P. Eriksson, and A. Hamsten
Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration
Blood,
May 15, 1999;
93(10):
3432 - 3441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Wamala, M. A. Murray, M. Horsten, M. Eriksson, K. Schenck-Gustafsson, A. Hamsten, A. Silveira, and K. Orth-Gomer
Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1999;
19(3):
485 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Philippou, S. J. Davidson, M. T. Mole, J. R. Pepper, J. F. Burman, and D. A. Lane
Two-Chain Factor VIIa Generated in the Pericardium During Surgery With Cardiopulmonary Bypass : Relationship to Increased Thrombin Generation and Heparin Concentration
Arterioscler. Thromb. Vasc. Biol.,
February 1, 1999;
19(2):
248 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Key, A. Slungaard, L. Dandelet, S. C. Nelson, C. Moertel, L. A. Styles, F. A. Kuypers, and R. R. Bach
Whole Blood Tissue Factor Procoagulant Activity Is Elevated in Patients With Sickle Cell Disease
Blood,
June 1, 1998;
91(11):
4216 - 4223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Orvim, R. M. Barstad, L. Orning, L. B. Petersen, M. Ezban, U. Hedner, and K. S. Sakariassen
Antithrombotic Efficacy of Inactivated Active Site Recombinant Factor VIIa Is Shear Dependent in Human Blood
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1997;
17(11):
3049 - 3056.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Cugno, M. Cicardi, B. Bottasso, R. Coppola, R. Paonessa, P. M. Mannucci, and A. Agostoni
Activation of the Coagulation Cascade in C1-Inhibitor Deficiencies
Blood,
May 1, 1997;
89(9):
3213 - 3218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Philippou, A. Adami, R. A. Amersey, P. J. Stubbs, and D. A. Lane
A Novel Specific Immunoassay for Plasma Two-Chain Factor VIIa: Investigation of FVIIa Levels in Normal Individuals and in Patients With Acute Coronary Syndromes
Blood,
February 1, 1997;
89(3):
767 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kapur, C. J. Hoffman, V. Bhushan, and M. B. Hultin
Postprandial Elevation of Activated Factor VII in Young Adults
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1996;
16(11):
1327 - 1332.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Silveira, F. Karpe, H. Johnsson, K. A. Bauer, and A. Hamsten
In Vivo Demonstration in Humans That Large Postprandial Triglyceride-Rich Lipoproteins Activate Coagulation Factor VII Through the Intrinsic Coagulation Pathway
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1996;
16(11):
1333 - 1339.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. H. Chung, N. Gikakis, A. K. Rao, T. A. Drake, R. W. Colman, and L. H. Edmunds Jr
Pericardial Blood Activates the Extrinsic Coagulation Pathway During Clinical Cardiopulmonary Bypass
Circulation,
June 1, 1996;
93(11):
2014 - 2018.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, T. Miyata, and K. Shimada
Factor VII Hyperactivity and Endothelial Cell Damage Are Found in Elderly Hypertensives Only When Concomitant With Microalbuminuria
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1996;
16(3):
455 - 461.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Zitoun, L. Bara, A. Basdevant, and M. M. Samama
Levels of Factor VIIc Associated With Decreased Tissue Factor Pathway Inhibitor and Increased Plasminogen Activator Inhibitor-1 in Dyslipidemias
Arterioscler. Thromb. Vasc. Biol.,
January 1, 1996;
16(1):
77 - 81.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Jang, L. A. Guzman, A. M. Lincoff, M. Gottsauner-Wolf, F. Forudi, C. E. Hart, D. W. Courtman, M. Ezban, S. G. Ellis, and E. J. Topol
Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model
Circulation,
November 15, 1995;
92(10):
3041 - 3050.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. A. Merlini, D. Ardissino, L. Oltrona, M. Broccolino, R. Coppola, and P. M. Mannucci
Heightened Thrombin Formation but Normal Plasma Levels of Activated Factor VII in Patients With Acute Coronary Syndromes
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1995;
15(10):
1675 - 1679.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, and T. Miyata
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
Arterioscler. Thromb. Vasc. Biol.,
August 1, 1995;
15(8):
1114 - 1120.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Moor, A. Silveira, F. van't Hooft, A. M. Suontaka, P. Eriksson, M. Blomback, and A. Hamsten
Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age : Role of Plasma Lipoproteins and Factor VII Genotype
Arterioscler. Thromb. Vasc. Biol.,
May 1, 1995;
15(5):
655 - 664.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Sakata, K. Kario, T. Matsuo, Y. Katayama, T. Matsuyama, H. Kato, and T. Miyata
Suppression of Plasma-Activated Factor VII Levels by Warfarin Therapy
Arterioscler. Thromb. Vasc. Biol.,
February 1, 1995;
15(2):
241 - 246.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Kazama, T. Hamamoto, D. C. Foster, and W. Kisiel
Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation
J. Biol. Chem.,
January 6, 1995;
270(1):
66 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Warn-Cramer and S. I. Rapaport
Evidence Suggestive of Activation of the Intrinsic Pathway of Blood Coagulation After Injection of Factor Xa/Phospholipid Into Rabbits
Arterioscler. Thromb. Vasc. Biol.,
January 1, 1995;
15(1):
133 - 139.
[Abstract]
[Full Text]
|
 |
|
|
|